enVVeno Medical Corporation (NVNO) Q1 2026 Earnings
NVNO·Reported May 7, 2026·After market close
Diluted EPS came in at $-5.89 (-2577.3% YoY), beat the $-8.40 consensus by $2.51.
Diluted EPS
$-5.89beat by $2.51
Consensus: $-8.40
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about enVVeno Medical Corporation's Q1 2026 earnings report.
enVVeno Medical Corporation (NVNO) reported Q1 2026 earnings on May 7, 2026 after market close.
enVVeno Medical Corporation reported diluted EPS of $-5.89 for Q1 2026.
EPS beat the consensus estimate of $-8.40 by $2.51.
Compared to the same quarter a year prior, diluted EPS declined 2577.3% from $-0.22.
You can read the 10-Q periodic report (0001493152-26-021490) directly on SEC EDGAR. The filing index links above go to sec.gov.